UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.5% in the third quarter, HoldingsChannel.com reports. The firm owned 4,548,725 shares of the financial services provider’s stock after acquiring an additional 68,579 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC’s holdings in MetLife were worth $375,179,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of MET. Acadian Asset Management LLC grew its stake in shares of MetLife by 7,837.0% during the second quarter. Acadian Asset Management LLC now owns 1,129,353 shares of the financial services provider’s stock worth $79,250,000 after purchasing an additional 1,115,124 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of MetLife by 22.4% during the second quarter. Dimensional Fund Advisors LP now owns 5,396,274 shares of the financial services provider’s stock worth $378,799,000 after purchasing an additional 988,666 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its stake in MetLife by 79.1% in the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider’s stock valued at $142,378,000 after acquiring an additional 762,291 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in MetLife by 347.4% in the second quarter. Public Sector Pension Investment Board now owns 432,887 shares of the financial services provider’s stock valued at $30,384,000 after acquiring an additional 336,127 shares in the last quarter. Finally, Legal & General Group Plc boosted its stake in MetLife by 5.4% in the second quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock valued at $371,993,000 after acquiring an additional 269,246 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.
Analyst Upgrades and Downgrades
Several research firms have issued reports on MET. TD Cowen upped their price objective on shares of MetLife from $97.00 to $99.00 and gave the company a “buy” rating in a research note on Wednesday. Bank of America decreased their price objective on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Monday. Morgan Stanley decreased their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Finally, Piper Sandler upped their price objective on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Fourteen equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of “Buy” and a consensus target price of $88.62.
MetLife Trading Up 0.6 %
NYSE MET opened at $88.25 on Friday. The stock has a market capitalization of $61.11 billion, a P/E ratio of 17.79, a P/E/G ratio of 0.81 and a beta of 1.05. MetLife, Inc. has a 52-week low of $62.89 and a 52-week high of $89.05. The firm has a 50-day moving average price of $83.19 and a 200 day moving average price of $76.46. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a yield of 2.47%. MetLife’s dividend payout ratio is currently 43.95%.
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- Find and Profitably Trade Stocks at 52-Week Lows
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Top Biotech Stocks: Exploring Innovation Opportunities
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Most active stocks: Dollar volume vs share volume
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.